The S segment of Rift Valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice

Journal of Virology

Volumn 74, Issue 3, 2000, Pages 1538-1543

  Vialat, P ^a   Billecocq, A ^a   Kohl, A ^a   Bouloy, M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BUNYAVIRUS; CELLULAR DISTRIBUTION; MOUSE; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIFT VALLEY FEVER BUNYAVIRUS; VERO CELL; VIRUS GENOME; VIRUS VIRULENCE;

ANIMALS; CERCOPITHECUS AETHIOPS; CYSTEINE ENDOPEPTIDASES; CYTOPLASM; GENOME, VIRAL; MICE; MULTIENZYME COMPLEXES; PLAQUE ASSAY; PROTEASOME ENDOPEPTIDASE COMPLEX; REASSORTANT VIRUSES; RIFT VALLEY FEVER VIRUS; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE;

EID: 0033982965     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.3.1538-1543.2000     Document Type: Article

References (30)

1. Anonymous. 1998. An outbreak of Rift Valley fever, Eastern Africa, 1997-98. Weekly Epidemiol. Rep. 73:105-112.
2. Billecocq, A., P. Vialat, and M. Bouloy. 1996. Persistent infection of mammalian cells by Rift Valley fever virus. J. Gen. Viral. 77:3053-3062.
3. Buchholz, U. J., S. Finke, and K. K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
4. Caplen, H., C. J. Peters, and D. H. Bishop. 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol. 66:2271-2277.
5. de Groot, R. J., T. Rumenapf, R. J. Kuhn, E. G. Strauss, and J. H. Strauss. 1991. Sindbis virus RNA polymerase is degraded by the N-end rule pathway. Proc. Natl. Acad. Sci. USA 88:8967-8971.
6. Endres, M. J., C. Griot, F. Gonzalez-Scarano, and N. Nathanson. 1991. Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J. Virol. 65:5465-5470.
7. Endres, M. J., A. Valsamakis, F. Gonzalez-Scarano, and N. Nathanson. 1990. Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones. J. Virol. 64:1927-1933.
8. Escoffier, C., S. Manie, S. Vincent, C. P. Muller, M. Billeter, and D. Gerlier. 1999. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73:1695-1698.
9. Gladding, R. L., A. L. Haas, D. L. Gronros, and T. G. Lawson. 1997. Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system. Biochem. Biophys. Res. Commun. 238:119-125.
10. Gonzalez-Scarano, F., and N. Nathanson. 1996. Bunyaviridae, p. 1473-1504. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Virology, 3rd ed. Raven Press, New York, N.Y.
11. Griot, C., A. Pekosz, D. Lukac, S. S. Scherer, K. Stillmock, D. Schmeidler, M. J. Endres, F. Gonzalez-Scarano, and N. Nathanson. 1993. Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J. Virol. 67:3861-3867.
12. He, B., G. P. Leser, R. G. Paterson, and R. A. Lamb. 1998. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 250:30-40.
13. Kato, A., K. Kiyotani, Y. Sakai, T. Yoshida, and Y. Nagai. 1997. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:578-587.
14. Kohl, A., V. di Bartolo, and M. Bouloy. 1999. The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy terminus. Virology 263:517-525.
15. Kretzschmar, E., R. Peluso, M. J. Schnell, M. A. Whitt, and J. K. Rose. 1996. Normal replication of vesicular stomatitis virus without C proteins. Virology 216:309-316.
16. Liljestrom, P., and H. Garoff. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9:1356-1361.
17. Muller, R., J. F. Saluzzo, N. Lopez, T. Dreier, M. Turell, J. Smith, and M. Bouloy. 1995. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am. J. Trop. Med. Hyg. 53:405-411.
18. Peters, C. J., and K. J. Linthicum. 1994. Rift Valley fever, p. 125-138. In G. W. Beran and J. H. Steele (ed.), Handbook of zoonoses, section B. Viral, 2nd ed. CRC Press, Boca Raton, Fla.
19. Pringle, C. R. 1996. Genetics and genome segment reassortment, p. 189-226. In R. M. Elliott (ed.), The viruses. The Bunyaviridae. Plenum Press, New York, N.Y.
20. Rodgers, S. E., J. L. Connolly, J. D. Chappell, and T. S. Dermody. 1998. Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a α1s-null mutant. J. Virol. 72:8597-8604.
21. Rodriguez, L. L., J. H. Owens, C. J. Peters, and S. T. Nichol. 1998. Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology 242:99-106.
22. Sall, A. A., P. M. de A. Zanotto, O. K. Sene, H. G. Zeller, J. P. Digoutte, Y. Thiongane, and M. Bouloy. 1999. Genetic reassortment of Rift Valley fever virus in nature. J. Virol. 73:8196-8200.
23. Saluzzo, J. F., and J. F. Smith. 1990. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8:369-375.
24. Schmaljohn, C. 1996. Bunyaviridae: the viruses and their replication, p. 1447-1471. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Raven Press, New York, N.Y.
25. Schwartz, O., V. Marechal, B. Friguet, F. Arenzana-Seisdedos, and J. M. Heard. 1998. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72:3845-3850.
26. Struthers, J. K., R. Swanepoel, and S. P. Shepherd. 1984. Protein synthesis in Rift Valley fever virus infected cells. Virology 134:118-124.
27. Teng, M. N., and P. L. Collins. 1999. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. J. Virol. 73:466-473.
28. Urquidi, V., and D. H. L. Bishop. 1992. Non-random reassortment between the tripartite RNA genomes of La Crosse and snowshoe hare viruses. J. Gen. Virol. 73:2255-2265.
29. Vialat, P., R. Muller, T. H. Vu, C. Prehaud, and M. Bouloy. 1997. Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res. 52:43-50.
30. Yadani, F.-Z., A. Kohl, C. Préhaud, A. Billecocq, and M. Bouloy. 1999. The carboxy-terminal acidic domain of Rift Valley fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J. Virol. 73:5018-5025.